Literature DB >> 4042450

Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia.

B Belhassen, A Pelleg.   

Abstract

Adenosine triphosphate (ATP) and adenosine exert strong and transient depressant effects on the sinoatrial and atrioventricular (AV) nodes of the human heart. The AV nodal effects of these drugs explain their high efficacy in either terminating AV re-entrant supraventricular tachycardia or in slowing ventricular rate during atrial tachyarrhythmias. Their very short half-life enables repeated administration of increased doses without reaching toxic effects and explains the transient character of their frequent but benign side effects. These agents represent a good alternative to verapamil in the acute management of paroxysmal supraventricular tachycardia both in infants and adults.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042450     DOI: 10.1002/clc.4960080903

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

3.  Recognizing Belhassen Ventricular Tachycardia and Preventing Its Misinterpretation as Supraventricular Tachycardia: An Unusual Case Report.

Authors:  Anthony Furiato; Alexander Prestley; Abdul Waheed; Salvador Villanueva
Journal:  Cureus       Date:  2020-08-17

4.  Druggability of Coronary Artery Disease Risk Loci.

Authors:  Vinicius Tragante; Daiane Hemerich; Mohammad Alshabeeb; Ingrid Brænne; Harri Lempiäinen; Riyaz S Patel; Hester M den Ruijter; Michael R Barnes; Jason H Moore; Heribert Schunkert; Jeanette Erdmann; Folkert W Asselbergs
Journal:  Circ Genom Precis Med       Date:  2018-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.